Patients and public health experts have come down heavily on the Central government for its stance in the Kerala High Court against offering support to the spinal muscular atrophy (SMA) patients ...

Genprex starts patient dosing in phase 2 expansion portion of Acclaim-3 study of Reqorsa Gene Therapy in combo with Tecentriq to treat SCLC: Austin, Texas Friday, January 24, 2025 ...

Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...

Syngene clinical trial subject part of pharmacokinetic study succumbs following complications: Our Bureau, Bengaluru Friday, January 24, 2025, 16:50 Hrs [IST] Syngene Internationa ...

Our Bureau, Bengaluru Friday, January 24, 2025, 14:30 Hrs [IST] ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

San Francisco, California Friday, January 24, 2025, 11:00 Hrs [IST] ...

Genethon & Eukarÿs enter strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies: Evry, France Friday, January 24, 2025, ...

Kelun-Biotech’s novel ADC drug SKB445 receives NMPA approval to treat advanced solid tumours: Chengdu Sichuan Province, PRC Friday, January 24, 2025, 15:00 Hrs [IST] Sichuan Kel ...

ImaginAb signs agreement to sell proprietary novel biologics technology platform to Telix Pharma: Inglewood, California Friday, January 24, 2025, 09:00 Hrs [IST] ImaginAb, Inc, a ...

The routine regulatory surveillance activity of the Central and State drug regulators has identified a total of 135 drug samples as Not of Standard Quality (NSQ) for the month of December, 2024. For ...